Eli Lilly vs Johnson & Johnson: Market Cap, Revenue and Profit Compared
Pharma heavyweights. Size and profitability side by side, using the exact figures from SEC filings.
Data updated: Nov 6, 2026 · Based on each company's latest annual report, so fiscal year ends may differ.
Quick answers
Which has the larger market cap?
Eli Lilly is worth about $1.221 trillion, 1.8 times Johnson & Johnson (about $666.8 billion). Based on the Nov 5, 2026 close.
Which has more revenue?
Johnson & Johnson brought in $94.193B in its latest fiscal year (FY2025), against $65.179B for Eli Lilly (FY2025).
Which is more profitable?
Eli Lilly has the higher net margin at 31.7%, against 28.5% for Johnson & Johnson. Out of every $100 of revenue, Eli Lilly keeps more as net income.
Which is growing faster?
Eli Lilly had the faster revenue growth in its latest fiscal year: +44.7%, against +6.0% for Johnson & Johnson.
Eli Lilly
LLY · FY2025 annual report
Revenue $65.179B
Net income $20.64B
- Cost of revenue17.0%
- R&D20.5%
- Other expenses23.1%
- Income taxes & other7.8%
- Net income31.7%
Johnson & Johnson
JNJ · FY2025 annual report
Revenue $94.193B
Net income $26.804B
- Cost of revenue32.1%
- R&D0.1%
- Other expenses33.2%
- Income taxes & other6.1%
- Net income28.5%
Size
| Item | Eli Lilly | Johnson & Johnson |
|---|---|---|
| Market cap | $1.221T#10 of 289 | $666.8B#15 of 289 |
| Revenue | $65.179B#60 of 299 | $94.193B#38 of 299 |
| Operating income | —Not ranked | —Not ranked |
| Net income | $20.64B#18 of 298 | $26.804B#12 of 298 |
| Free cash flow | —Not ranked | $19.698B#14 of 261 |
| Total assets | $112.476B#74 of 299 | $199.21B#42 of 299 |
| Dividends paid | $5.384B#28 of 214 | —Not ranked |
| Dividend per share | $6.23#30 of 205 | $5.14#44 of 205 |
| Dividend yield | 0.5%#182 of 203 | 1.9%#88 of 203 |
Profitability and stability
| Item | Eli Lilly | Johnson & Johnson |
|---|---|---|
| Net margin | 31.7%#29 of 298 | 28.5%#44 of 298 |
| Revenue growth | +44.7%#11 of 299 | +6.0%#183 of 299 |
| Operating margin | —Not ranked | —Not ranked |
| FCF margin | —Not ranked | 20.9%#83 of 261 |
| ROE | 101.2%#15 of 276 | 35.0%#69 of 276 |
| Debt-to-equity | 323.9%#193 of 244 | 144.3%#107 of 244 |